Literature DB >> 1682439

Melatonin-induced relaxation of rat aorta: interaction with adrenergic agonists.

L B Weekley1.   

Abstract

The influence of melatonin on alpha- and beta-adrenergic responses of vascular smooth muscle ex vivo were examined in these experiments. Melatonin caused a dose-dependent relaxation of precontracted (30 mM KCl) vascular smooth muscle. This response was not affected by the removal of vascular endothelium. Melatonin (10 nM) reduced the efficacy, but not potency, of the contractile responses to methoxamine and clonidine. Melatonin had no effect on the vascular beta-adrenergic response to isoproterenol. Pretreatment of vascular rings with lithium sulfate (0.1 mM) completely blocked the relaxation in response to melatonin, suggesting that the inositol phosphate pathway may be involved in this relaxation. Furthermore, pretreatment of vascular rings with phorbol 12-myristate-13-acetate, an activator of protein kinase C, antagonized the relaxation response to melatonin. Pharmacologic doses of melatonin (0.1 mM) slightly impaired the vascular smooth muscle response to calcium. These data indicate that melatonin per se is capable of relaxing vascular smooth muscle and that low doses of melatonin impair alpha-1 and alpha-2 adrenergic responses without changes in the beta adrenergic response of vascular smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1682439     DOI: 10.1111/j.1600-079x.1991.tb00823.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  11 in total

1.  Effects of melatonin on pulmonary and coronary vessels are exerted through perivascular nerves.

Authors:  L B Weekley
Journal:  Clin Auton Res       Date:  1993-02       Impact factor: 4.435

2.  MT2 receptors mediate the inhibitory effects of melatonin on nitric oxide-induced relaxation of porcine isolated coronary arteries.

Authors:  Radhika R Tunstall; Praveen Shukla; Anna Grazul-Bilska; Chengwen Sun; Stephen T O'Rourke
Journal:  J Pharmacol Exp Ther       Date:  2010-10-19       Impact factor: 4.030

3.  Influence of melatonin on bovine pulmonary vascular and bronchial airway smooth muscle tone.

Authors:  L B Weekley
Journal:  Clin Auton Res       Date:  1995-02       Impact factor: 4.435

4.  Urinary melatonin and risk of incident hypertension among young women.

Authors:  John P Forman; Gary C Curhan; Eva S Schernhammer
Journal:  J Hypertens       Date:  2010-03       Impact factor: 4.844

5.  Dose-dependent dual effect of melatonin on ototoxicity induced by amikacin in adult rats.

Authors:  Tamer Erdem; Orhan Ozturan; Mustafa Iraz; Murat Cem Miman; Ercument Olmez
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-05-28       Impact factor: 2.503

6.  Low urinary 6-sulfatoxymelatonin levels in patients with severe congestive heart failure.

Authors:  Luis Girotti; Manuel Lago; Oscar Ianovsky; Marcelo V Elizari; Andrés Dini; Santiago Pérez Lloret; Liliana E Albornoz; Daniel P Cardinali
Journal:  Endocrine       Date:  2003-12       Impact factor: 3.633

7.  Melatonin inhibits nitric oxide signaling by increasing PDE5 phosphorylation in coronary arteries.

Authors:  Praveen Shukla; Chengwen Sun; Stephen T O'Rourke
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-10-19       Impact factor: 4.733

8.  Aerobic exercise enhanced endothelium-dependent vasorelaxation in mesenteric arteries in spontaneously hypertensive rats: the role of melatonin.

Authors:  Fang Qiu; Xiaodong Liu; Yanyan Zhang; Ying Wu; Daliao Xiao; Lijun Shi
Journal:  Hypertens Res       Date:  2018-07-02       Impact factor: 3.872

Review 9.  Peripheral and central effects of melatonin on blood pressure regulation.

Authors:  Olga Pechanova; Ludovit Paulis; Fedor Simko
Journal:  Int J Mol Sci       Date:  2014-10-08       Impact factor: 5.923

Review 10.  A Review of Data of Findings on Night Shift Work and the Development of DM and CVD Events: a Synthesis of the Proposed Molecular Mechanisms.

Authors:  S Strohmaier; E E Devore; Y Zhang; E S Schernhammer
Journal:  Curr Diab Rep       Date:  2018-10-20       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.